NCAM1 and sarcoma: Dancsok et al. observed that a high CD56+ score was linked to significantly worse OS in mutation- and/or copy number-driven sarcomas (including WDLPS and DDLPS) while the overall CD56 expression in this cohort was remarkably low [86].